- Filed
- May 18, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 18, 2026 | 221.94M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 216.01M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 212.26M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 8.37M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 8.16M sh |
| Capex | Q3 2026 · Mar 31, 2026 | $40.7K |
| Capex | Q3 2026 · Mar 31, 2025 | $18.86K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$14.82M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$2.23M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $4.05M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $1.46M |
| Stockholders Equity restated | Q3 2026 · Mar 31, 2026 | $60.34M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $93.82M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $172.5M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $1.47M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $1.65M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $2.21M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $3.06M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $3.74M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $6.9M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $2.85M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $7.05M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $7M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $20.26M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $3.82M |
| Total Assets restated | Q3 2026 · Mar 31, 2026 | $67.39M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $8.47M |
| Eps Diluted restated | Q3 2026 · Mar 31, 2026 | −$0.17 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2026 | −$0.73 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.10 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.33 |
| Eps Basic restated | Q3 2026 · Mar 31, 2026 | −$0.17 |
| Eps Basic restated | Q3 2026 · Mar 31, 2026 | −$0.73 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.10 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.33 |
| Sga Expense restated | Q3 2026 · Mar 31, 2026 | $18.4M |
| Sga Expense restated | Q3 2026 · Mar 31, 2026 | $48.33M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $968.26K |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $2.86M |
| Net Income restated | Q3 2026 · Mar 31, 2026 | −$37.26M |
| Net Income restated | Q3 2026 · Mar 31, 2026 | −$154.99M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$104.36M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$13.37M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$809.35K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$2.67M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$1.01M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$856.08K |
| Operating Income restated | Q3 2026 · Mar 31, 2026 | −$18.98M |
| Operating Income restated | Q3 2026 · Mar 31, 2026 | −$47.91M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$716.8K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$2.5M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | −$419.26K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $846.49K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $311.13K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $558.64K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $962.95K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $1.67M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $246.78K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $621.44K |
| Revenue | Q3 2026 · Mar 31, 2026 | $543.69K |
| Revenue | Q3 2026 · Mar 31, 2026 | $2.52M |
| Revenue | Q3 2026 · Mar 31, 2025 | $557.92K |
| Revenue | Q3 2026 · Mar 31, 2025 | $1.18M |